propranolol + levodopa + benserazide

This is a combination therapy consisting of propranolol (a beta-blocker), levodopa (a dopamine precursor), and benserazide (a decarboxylase inhibitor). The combination is used primarily for managing Parkinson's disease symptoms, particularly tremor. Levodopa helps correct the dopamine deficiency in the brain that causes Parkinson's symptoms, while benserazide prevents the peripheral conversion of levodopa to dopamine, reducing side effects and allowing more levodopa to reach the brain. Propranolol serves as an adjuvant therapy specifically targeting tremor symptoms that may not be adequately controlled by levodopa-benserazide alone.

Brand names

Madopar

Other names

propranolol + levodopa/benserazidepropranolol + levodopa plus benserazide